Search results
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 2 days agoThe company even upped its full-year profit outlook. But AbbVie stock fell all the same, closing...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 14 hours agoThe Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure...
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 2 days agoAbbVie (ABBV) delivered earnings and revenue surprises of 2.21% and 2.65%, respectively, for the...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 2 days agoAbbVie is "firing on all cylinders," an analyst said Friday after the pharma giant beat Wall...
Abbvie Inc (ABBV) Shares Up Despite Recent Market Volatility – News Heater
NewsHeater· 7 days agoThe stock price of Abbvie Inc (NYSE: ABBV) has surged by 1.06 when compared to previous closing price of 164.66, but the company has seen a 2.54% gain in ...
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoOn today's conference call, non-GAAP financial measures will be used to help investors understand AbbVie's business performance. Should you invest $1,000...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 1 day agoPfizer expects acquisitions completed in recent years and some that are yet to be made should...
AbbVie earnings beat by $0.04, revenue topped estimates By Investing.com
Investing.com· 2 days agoAbbVie earnings beat by $0.04, revenue topped estimates
Buying the Dip in These 3 Undervalued Dividend Stocks
Motley Fool via Yahoo Finance· 6 days ago*Stock prices used were end-of-day prices of April 18, 2024. The video was published on April 19,...
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks via Yahoo Finance· 2 days agoAbbVie Inc. ABBV reported adjusted earnings of $2.31 per share for first-quarter 2024, beating the...
